A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide Plus Peginterferon and Ribavirin in Naïve Patients With Chronic Hepatitis C Genotype 1 Infection: Final Report

Autor:	Mitchell L. Shiffman, Joseph K. Lim, Bruce R. Bacon, Arthur Berman, Emmet B. Keeffe, Vinod K. Rustgi
Rok vydání:	2010
Předmět:	medicine.medical_specialty Hepatology business.industry Ribavirin Gastroenterology Placebo-controlled study Nitazoxanide Double blind Therapy naive chemistry.chemical_compound chemistry Chronic hepatitis Internal medicine Genotype Medicine business medicine.drug
Zdroj:	Gastroenterology. 139:e18
ISSN:	0016-5085
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::870cd0caff11b383a1139381f53d79af https://doi.org/10.1053/j.gastro.2010.05.067 Zobrazit plný text záznamu